Belgian Biotech Stock News

argenx (ENXTBR:ARGX) has achieved a notable turnaround to profitability over the past year, posting high-quality earnings and sustaining a five-year annual earnings growth rate of 52.7%. Looking ahead, consensus forecasts point to annual earnings growth of 28%, outpacing the Belgian market’s 15.6% projection, while revenue is also expected to rise by 18.5% per year compared to an 8.4% market average. Investors are weighing these strong growth figures and recent profitability against...

Aedifica announced in late October that it has raised its 2025 earnings guidance and reported solid nine-month results, with sales reaching €271.79 million and net income of €194.12 million. A key highlight is the 3.1% like-for-like rental income growth, reflecting improved operational momentum alongside continued asset rotation and new investment initiatives. We'll explore how the uplifted earnings forecast reinforces Aedifica's investment narrative and signals continued operating momentum...

Cenergy Holdings (ENXTBR:CENER) has quietly posted some eye-catching returns over the past year, with shares climbing more than 70%. This strong momentum puts the stock in focus for investors who want to understand what is driving its performance. See our latest analysis for Cenergy Holdings. Cenergy Holdings’ 71% total shareholder return over the past year stands out against a backdrop of accelerating momentum. The company has also seen a 36.7% share price return in the last 90 days and...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

In recent announcements, Cmb.Tech NV reported the delivery of five newbuilding vessels across several categories and revealed the sale of multiple ships, generating significant capital gains set for the third and fourth quarters of 2025. These developments highlight how Cmb.Tech is actively renewing its fleet and managing assets to support operational improvements and future revenue stability. To understand the impact on Cmb.Tech's investment narrative, we will examine how these fleet...

Aedifica (ENXTBR:AED) posted a net profit margin of 62.1%, doubling last year’s margin of 31.1%. EPS growth soared by 115.1% as the company rebounded from a 5-year annual decline of 10.7%. Revenue is forecast to grow 3% annually, below the Belgian market's 8.4%, but earnings are projected to climb 18.8% per year, outpacing the market's 15.6% rate. Positive investor sentiment is likely to focus on the strong momentum in profitability and attractive valuation metrics, even as financial...

It's not a stretch to say that Barco NV's ( EBR:BAR ) price-to-earnings (or "P/E") ratio of 13.6x right now seems quite...

Solvay (ENXTBR:SOLB) is garnering attention as its advancements in bio-based and recyclable polymer technologies align with France’s fast-evolving market and regulatory push for circular economy solutions. Investors are watching how these initiatives shape long-term value. See our latest analysis for Solvay. Solvay’s recent advances in sustainable polymers come at an interesting time for shareholders, given the stock’s hefty 13.44% decline in share price so far this year. While the 1-year...

Fagron NV's ( EBR:FAGR ) price-to-earnings (or "P/E") ratio of 17.5x might make it look like a sell right now compared...

Nyxoah SA ( EBR:NYXH ) shareholders should be happy to see the share price up 14% in the last month. But that doesn't...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Key Insights The projected fair value for Spadel is €199 based on 2 Stage Free Cash Flow to Equity With €224 share...

With a price-to-sales (or "P/S") ratio of 0.6x Immobel SA ( EBR:IMMO ) may be sending very bullish signals at the...

The simplest way to invest in stocks is to buy exchange traded funds. But you can significantly boost your returns by...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Cofinimmo (ENXTBR:COFB) reported a 20.9% annual decline in earnings over the past five years, but has just moved back into profitability despite a significant non-recurring loss of €52.6 million for the 12 months ending September 2025. Looking ahead, company earnings are forecast to grow at 13.1% per year, trailing the Belgian market average of 15.3%, while revenue is expected to decrease at an annual rate of -1.1% over the next three years. See our full analysis for Cofinimmo. Let’s see how...

Cmb.Tech (ENXTBR:CMBT) stock is catching investors’ attention today as recent trading patterns point to shifts in sentiment. Shares have seen mixed returns lately, bringing valuation and future prospects into sharper focus for the market. See our latest analysis for Cmb.Tech. While Cmb.Tech’s share price ticked higher over the past quarter, overall momentum has cooled, with a recent one-year total shareholder return of -41.5%. Investors seem to be weighing past volatility against the...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Most readers would already be aware that Viohalco's (EBR:VIO) stock increased significantly by 27% over the past three...

As the European market navigates a mixed landscape, with the pan-European STOXX Europe 600 Index inching higher amid dovish signals from the U.S. Federal Reserve and easing trade tensions, investors are keenly observing economic indicators like industrial production and labor market dynamics. In this environment, identifying promising small-cap stocks that can withstand volatility and capitalize on emerging opportunities is crucial for enhancing portfolio resilience.

Anheuser-Busch InBev (ENXTBR:ABI) shares have seen their ups and downs over the past few months. Recent price action reflects mixed sentiment from investors. The stock’s movement offers a window into the ongoing debates about value and future growth potential. See our latest analysis for Anheuser-Busch InBev. The latest share price of Anheuser-Busch InBev stands at $52.86, a level that reflects both recent volatility and the broader debate about the company’s long-term trajectory. Momentum...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...